Ultrasound Guided Median Nerve Hydrodissection Using Dextrose

to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome

Completed

Looking for future studies?

Key information

Conditions

Carpal Tunnel Syndrome Cumulative Trauma Disorders Median Neuropathy Mononeuropathies Nerve Compression Syndromes Nervous System Diseases Neuromuscular Diseases Peripheral Nervous System Diseases Sprains and Strains Wounds and Injuries

Age range

20 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Baghdad Medical City

Baghdad, 10001, Iraq

About this study

in some cases there is prohibition to use steroid with example the patient rejection to use steroid the maneuver planned median nerve hydrodissection using ultrasound and 10 mld of dextrose 5%, unleash the median nerve for the surrounding structure and short follow up planned to be 2 weeks

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

severe carpal tunnel syndrome failed medical management -

Exclusion criteria

previous failed surgery previous failed injection previous failed trial of hydrodissection cervical or brachial nerve entrapment wrist osteoarthritis or rheumatoid pregnant diabetes mellitus

Treatment and study plan

dextrose 5% median nerve hydrodissection

Procedure

planned to be a good alternative to steroid hydrodissection

Primary outcomes

pain relief in 2 weeks follow up

Time frame: 6 months

difference in sensory and functional symptoms post median nerve hydrodissection using dextrose and compare this effect with steroid population arm using Boston questionnaire

Sponsors and collaborators

Lead sponsor

Iraqi Board of medical specialties

Other

Registry information

Official study title

Efficacy of Dextrose 5% in Comparison With Steroid in Median Nerve Ultrasound Guided Hydrodissection in Patients With Carpal Tunnel Syndrome

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Feb 13, 2023
Registry last updated: Sep 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed